Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy

Summary

The purpose of this study is to evaluate the efficacy and safety of intramuscular administration of Engensis on pain in participants with painful diabetic peripheral neuropathy in the feet and lower legs, as compared to Placebo, as a second Phase 3, well controlled study, sufficient in supporting the efficacy and safety of Engensis.

Timeline

Start

2020-11-20

Primary completion

2023-03-24

Completion

2024-07-31

Drugs

Indications